San Diego County adopts a new substance abuse prevention plan for schools, led by DA Summer Stephan, integrating five drug ...

Binghamton welcomed hundreds of health experts for a two-day conference centered around drug addiction and harm reduction.

Los Angeles is making strides toward a guaranteed basic income program that would target domestic abuse survivors. Members of the Los Angeles City Council unanimously voted this week to advance a ...

The Centers for Medicare & Medicaid Services (CMS) rolled out guidance Oct. 2 as stakeholders prep for the second round of the drug price negotiation program ... a fact sheet (PDF) said.

an addiction medicine specialist and the lead physician of the Mayo Clinic opioid stewardship program in Arizona, explains that in an effort to help combat opioid-related drug abuse, many doctors ...

The former CEO of a Connecticut vocational program for disabled adults was recently found guilty ... Anyone with information about suspected fraud or abuse in the healthcare system is asked ...

an organization providing Vermont’s youth with peer-to-peer mentoring services which prevent high-risk behaviors such has substance misuse and abuse. “The DREAM Project has played an important role in ...

The program facilitates discussions — coined PEP Talks — between students and medical professionals to present tactics to recognize and treat substance abuse. PEP offers four pre-designed curriculums ...

The Family Guidance Center started a youth substance abuse program this summer that’s designed for kids ages 12 to 17 who are struggling with addiction. Counselors have seen success so far but ...

little headway had been made on a new drug rehabilitation program. The NHL and the NHLPA did, however, implement a Substance Abuse and Behavioral Health (SABH) program in 1996, which remains in ...

Although the former Bravo star went to rehab in 2011, her substance abuse issues have been brought up numerous times over the years. If you or someone you know is affected by any of the issues ...

today announced that the U.S. Food and Drug Administration (FDA) has approved COBENFY™ (xanomeline and trospium chloride), an oral medication for the treatment of schizophrenia in adults.